HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.

Abstract
NLRP1 (NLR family, pyrin domain containing 1), the first NLR protein, described to form an inflammasome, plays critical roles in innate immunity and inflammation. However, NLRP1 has not been reported to be linked to LUAD (lung adenocarcinoma) risk, prognosis, immunotherapy or any other treatments. This research aimed to explore the prognostic value and mechanism of NLRP1 in LUAD. We performed bioinformatics analysis on LUAD data downloaded from TCGA (The Cancer Genome Atlas) and GEO (Gene Expression Omnibus), and jointly analyzed with online databases such as TCGAportal, LinkedOmics, TIMER, ESTIMATE and TISIDB. NLRP1 expression of LUAD tissue was considerably lower than that in normal lung tissue. Decreased NLRP1 expression of LUAD was associated with relatively high pathological, T and N stages. Kaplan-Meier survival analysis indicated that patients with low NLRP1 expression had a worse prognosis than those with high expression. Multivariate Cox analysis further showed that NLRP1 expression level was an independent prognostic factor of LUAD. Moreover, the level of NLRP1 expression was positively linked to the degree of infiltration of various TIICs (tumor-infiltrating immune cells). Our findings confirmed that reduced expression of NLRP1 was significantly related to poor prognosis and low degree of immune cell infiltration in LUAD patients.
AuthorsEdward Shen, Ying Han, Changjing Cai, Ping Liu, Yihong Chen, Le Gao, Qiaoqiao Huang, Hong Shen, Shan Zeng, Min He
JournalAging (Aging (Albany NY)) Vol. 13 Issue 5 Pg. 7570-7588 (03 03 2021) ISSN: 1945-4589 [Electronic] United States
PMID33658393 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • NLR Proteins
  • NLRP1 protein, human
Topics
  • Adenocarcinoma of Lung (diagnosis, immunology, metabolism, mortality)
  • Female
  • Humans
  • Lung (immunology, pathology)
  • Lung Neoplasms (diagnosis, immunology, metabolism, mortality)
  • Lymphocytes, Tumor-Infiltrating (pathology)
  • Male
  • Middle Aged
  • NLR Proteins (metabolism)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: